Search

Search Results

• GLP-1 Agonists and Dual Agonists in Obesity Treatment: Benefits, Risks, and Clinical Challenges in Geriatric Patients

  Lidia Wydeheft , Justyna Jusiak , Paulina Halik, Paulina Malon, Kornelia Kędziora-Kornatowska

  67673

  2026-01-10
• Glucagon-Like Peptide-1 Receptor Agonists in Obesity Management: Mechanisms, Efficacy, and Safety

  Michał Stasiak, Wiktor Żyro, Karolina Woźniak, Katarzyna Żyro, Franciszek Glapiński, Adam Woźniak

  60634

  2025-06-17
• The Impact of GLP-1 Receptor Agonists on Body Composition and Musculoskeletal Integrity: A Review of Mechanisms, Protective Strategies, and Clinical Perspectives

  Szymon Domagała, Zuzanna Wiater, Aleksandra Włodarczyk, Karolina Brankowska, Marta Jakubowska, Michał Olejnik, Paulina Tymińska, Piotr Artur Górka, Julia Frączek, Witold Kądziołka

  69771

  2026-03-24
• The Potential Role of Glucagon-Like Peptide-1 Receptor Agonists in Polycystic Ovary Syndrome: A Narrative Review

  Kamil Turlej, Dmytro Kowalczuk, Viktoryia Kasianik, Darya Lazitskaya, Mykola Sobchynskyi, Valeryia Milasheuskaya, Andrii Myrnyi, Iga Kiełbaszewska, Natallia Surosz, Katsiaryna Miraniuk

  61264

  2025-07-07
• Synergistic Role of Creatine Monohydrate in Mitigating Skeletal Muscle Wasting and Strength Decline during GLP-1 Receptor Agonist Therapy: A Comperhensive Review

  Aladdin Salama, Shafea Abdulla, Anhelina Kaminskaya, Sofiia Ivanchuk, Tetiana Savchak, Aleksandra Kurek, Dominika Domińczak, Patryk Górecki, Aleksandra Głowacka, Hubert Feretycki

  70226

  2026-04-04
• Semaglutide, liraglutide and tirzepatide: Comparison of effectiveness in the treatment of obesity – a literature review

  Karolina Baran, Marlena Jankowska, Natalia Jańczyk, Karolina Mędrysa, Jakub Pokrzepa, Michał Presak, Gabriela Blecharz, Julia Szwech, Alicja Winkowska, Jan Machalica

  56469

  2024-12-26
• Neuroprotective Mechanisms of GLP‑1 Pathway Activation in Parkinson’s Disease - Foundations For Future Disease‑Modifying Strategies

  Gabriela Chmiel, Patryk Bachurski, Paweł Kalinowski, Maja Międlar, Martyna Muda, Szymon Pacek, Elisabetta Pierzga, Karol Paweł Wiśniewski, Paweł Witkowski, Bartosz Zarański

  68253

  2026-02-01
• Dietary Modulation and Clinical Outcomes During GLP-1 Receptor Agonist Therapy. A Literature Review

  Kacper Rychlica, Konrad Gawin, Wiktoria Zawiślak, Anita Ignasiak, Michał Cisowski, Maria Dąbrowska, Jolanta Cholewińska-Rychlica, Paulina Madura, Daria Mrozik-Gałecka

  67649

  2026-01-18
• Therapeutic Spectrum of GLP-1 Receptor Agonist: From Glycemic Control to Metabolic Protection

  Marta Kamińska, Wiktoria Kotlarz, Matylda Kuczma, Adrianna Klimczak, Barbara Pietrzak, Mikołaj Patelski, Maciej Czapla, Mateusz Surma, Wiktoria Mikusek, Jakub Molenda

  68001

  2026-01-17
• Beyond Glycemic Control: The Expanding Role of GLP-1 Analogues in Type 2 Diabetes and Metabolic Health

  Michał Mazur, Dorota Waz, Jakub Szarłowicz, Zofia Goliszek, Karolina Łucja Sobek, Wiktoria Tabin-Barczak, Aldona Sokołowska, Klaudia Fikas, Kamil Chwaliszewski, Sebastian Samuła

  56722

  2024-12-20
• Tirzepatide - a new drug with great potential in controlling glycemia and body weight

  Magdalena Stabrawa , Filip Prusinowski , Maria Teresa Sarata , Aleksandra Kutaj, Tatyana Savitskaya, Ignacy Hatala, Kiryl Savitski

  69364

  2026-03-06
• Injections for weight loss: what’s new in GLP-1 RAs for obesity treatment – review

  Małgorzata Maria Zając, Radosław Zaucha, Julia Silldorff, Stanisław Anczyk, Marcin Dudek, Tomasz Fura, Zuzanna Felińska, Oliwia Iszczuk, Magdalena Gajkiewicz, Magdalena Jaskółka

  53875

  2024-08-19